Pharmacy alumni and faculty work with research team to develop North America’s first test to predict Kawasaki disease A new tool under development by University at Buffalo researchers could one day help clinicians better predict resistance to immunoglobulin therapy...
Read More
MIS-C and KD are on the same immune response continuum as COVID-19 A recent study revealed that MIS-C and KD are on the same immune response continuum as COVID-19, with MIS-C being a more severe version of the response...
Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial Summary Background Although intravenous immunoglobulin (IVIG) is effective therapy for Kawasaki disease, 10–20% of patients have recrudescent fever...
Same Treatment Tested for Kids with Kawasaki Disease and Rare COVID-19 Reaction In a pair of new studies, published online October 26 and August 31, 2021, two collaborating teams of researchers at University of California San Diego School of...
Researcher: Kawasaki Disease Spike In San Diego Likely Tied To Aerosol Particles An unusual and potentially deadly disease is making a growing number of San Diego County children sick, and researchers say it’s caused by something in the air....
Fever, conjunctivitis, rash, and belly pain KD case study written by two medical doctors highlights that children with KD and prominent GI (gastrointestinal (GI) symptoms of abdominal pain and diarrhea) or hepatobiliary (having to do with the liver plus...
Treatment Intensification in Patients With Kawasaki Disease and Coronary Aneurysm at Diagnosis Coronary artery aneurysms (CAA) are a serious complication of Kawasaki disease. Treatment with intravenous immunoglobulin (IVIg) within 10 days of fever onset reduces the risk of CAA...
Etanercept With IVIg for Acute Kawasaki Disease: A Randomized Controlled Trial Dr. Michael A. Portman and colleagues have published the results of a clinical trial showing benefits by etanercept (brand name Enbrel) for Kawasaki Disease patients. The results were...
Groundbreaking research at Seattle Children’s Hospital to help diagnose rare health condition SEATTLE – A groundbreaking researching happening right here in Washington is giving doctors new hope at better treating and diagnosing a rare health condition called Kawasaki disease....
New study aims to better understand Kawasaki disease BALTIMORE – A new study looks to define the antibody characteristics, including clonality, of plasmablasts during Kawasaki Disease (KD). Findings from the study will be presented during the Pediatric Academic Societies...